SCHEMBL734715

SCHEMBL734715

CN(C)C1(c2ccccc2)CC=C(c2[nH]c3ccccc3c2CCn2cnc3ccccc32)CC1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.39
OPRM1 P35372 5/20 0.38
OPRL1 P41146 4/20 0.38
MAPT P10636 2/20 0.38
PKM P14618 1/20 0.38
TDP1 Q9NUW8 1/20 0.36
HTR2A P28223 6/20 0.35
HTR2C P28335 5/20 0.35
DRD2 P14416 3/20 0.35
OGFRL1 Q5TC84 2/20 0.35
LMNA P02545 2/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
P2RX7 Q99572 1/20 0.34
DRD4 P21917 1/20 0.34
DRD3 P35462 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL733645 0.91 OPRM1 (0.40) HTTOPRM1OPRL1MAPTPKM
SCHEMBL734842 0.83 OPRM1 (0.38) OPRM1OPRL1MAPTOGFRL1SMN1; SMN2
SCHEMBL733107 0.81 HTR2A (0.55) OPRM1OPRL1HTR2AHTR2CDRD2
SCHEMBL734380 0.81 EGLN3 (0.40) OPRM1OPRL1HTR2AHTR2CDRD2
SCHEMBL734279 0.81 OPRM1 (0.44) OPRM1OPRL1HTR2AHTR2CDRD2
SCHEMBL735512 0.80 OPRM1 (0.44) OPRM1OPRL1HTR2AHTR2CDRD2
SCHEMBL735785 0.80 OPRM1 (0.42) OPRM1OPRL1HTR2AHTR2CDRD2
SCHEMBL735588 0.80 HTR2A (0.55) OPRM1OPRL1HTR2AHTR2CDRD2
SCHEMBL735511 0.80 HTR2A (0.46) OPRM1OPRL1HTR2AHTR2CDRD2
SCHEMBL735786 0.80 OPRM1 (0.42) HTTOPRM1OPRL1MAPTHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044016-B1 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM GRUENENTHAL GMBH (DE) 2012-12-05 EP disclosed
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US disclosed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US disclosed
EP-2044016-A2 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM Grünenthal GmbH (DE) 2009-04-08 EP disclosed
WO-2008009415-A2 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1- AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM Grünenthal GmbH (DE) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES CYP3A43, HMGCR, ABCG2 HTT 247/4885OPRM1 1029/4885OPRL1 1562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.